Kalaris Therapeutics Inc

KLRS

Add to Watchlist

3.510USD

+0.030+0.86%

Close 07-31 16:00（ET）Quotes delayed by 15 min

80.70MMarket Cap

LossP/E TTM

Kalaris Therapeutics Inc

3.510

+0.030+0.86%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Kalaris Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-07-31

Previous score

6.34

Change

The current valuation score of Kalaris Therapeutics Inc is 6.34, ranking 312 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.46, which is -99.81% below the recent high of -0.01 and -50.14% above the recent low of -6.70.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.